Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression.
Beveridge RA, Miller JA, Kales AN, Binder RA, Robert NJ, Harvey JH, Windsor K, Gore I, Cantrell J, Thompson KA, Taylor WR, Barnes HM, Schiff SA, Shields JA, Cambareri RJ, Butler TP, Meister RJ, Feigert JM, Norgard MJ, Moraes MA, Helvie WW, Patton GA, Mundy LJ, Henry D, Sheridan MJ, et al. Beveridge RA, et al. Among authors: taylor wr. Cancer Invest. 1998;16(6):366-73. doi: 10.3109/07357909809115775. Cancer Invest. 1998. PMID: 9679526 Clinical Trial.
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.
Beveridge RA, Miller JA, Kales AN, Binder RA, Robert NJ, Heisrath-Evans J, Koczyk-Scripka K, Pashko S, Norgard MJ, Barnes HM, Taylor WR, Thompson KA, Smith LF, Ueno WM, Dobrzynski RF, Warren RD, Katcher D, Byrne PJ, Dunning DM, Winokur SH, Lockey JL, Cambareri RJ, Butler TP, Meister RJ, Fiegert JM. Beveridge RA, et al. Among authors: taylor wr. Support Care Cancer. 1997 Jul;5(4):289-98. doi: 10.1007/pl00009894. Support Care Cancer. 1997. PMID: 9257425 Clinical Trial.
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV).
Jittamala P, Boyd S, Schilling WHK, Watson JA, Ngamprasertchai T, Siripoon T, Luvira V, Batty EM, Wongnak P, Esper LM, Almeida PJ, Cruz C, Ascencao FR, Aguiar RS, Ghanchi NK, Callery JJ, Singh S, Kruabkontho V, Ngernseng T, Tubprasert J, Madmanee W, Suwannasin K, Promsongsil A, Hanboonkunupakarn B, Poovorawan K, Potaporn M, Srisubat A, Loharjun B, Taylor WRJ, Qamar F, Kazi AM, Beg MA, Chommanam D, Vidhamaly S, Chotivanich K, Imwong M, Pukrittayakamee S, Dondorp AM, Day NPJ, Teixeira MM, Piyaphanee W, Phumratanaprapin W, White NJ; PLATCOV Collaborative Group. Jittamala P, et al. Among authors: taylor wrj. EClinicalMedicine. 2025 Jan 18;80:103036. doi: 10.1016/j.eclinm.2024.103036. eCollection 2025 Feb. EClinicalMedicine. 2025. PMID: 39896880 Free PMC article.
Steps to Avoid Falls in the Elderly - a TECHnology Enhanced Intervention (SAFE-TECH) study: randomized controlled trial protocol for a community-based, multi-component fall prevention program.
Lai WX, Koh V, Goh JW, Tan KY, Tan KZ, Pai SGS, Taylor WR, Visaria A, Singh NB, Chan AWM, Matchar DB. Lai WX, et al. Among authors: taylor wr. BMC Public Health. 2024 Dec 18;24(1):3464. doi: 10.1186/s12889-024-20947-2. BMC Public Health. 2024. PMID: 39695436 Free PMC article.
962 results